Cart
sales@molnova.com
RO6889678
CAS No. 1578153-27-1
RO6889678( RO 6889678 )
Catalog No. M12255 CAS No. 1578153-27-1
RO6889678 is a highly potent inhibitor of HBV capsid formation with attributes that are favorable for targeting the liver, whilst maintaining moderate peripheral exposure.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 161 | In Stock |
|
| 2MG | 93 | In Stock |
|
| 5MG | 131 | In Stock |
|
| 10MG | 188 | In Stock |
|
| 25MG | 269 | In Stock |
|
| 50MG | 420 | In Stock |
|
| 100MG | 618 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRO6889678
-
NoteResearch use only, not for human use.
-
Brief DescriptionRO6889678 is a highly potent inhibitor of HBV capsid formation with attributes that are favorable for targeting the liver, whilst maintaining moderate peripheral exposure.
-
DescriptionRO6889678 is a highly potent inhibitor of HBV capsid formation with attributes that are favorable for targeting the liver, whilst maintaining moderate peripheral exposure.HBV InfectionPhase 1 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsRO 6889678
-
PathwayMicrobiology/Virology
-
TargetHBV
-
RecptorHBV
-
Research AreaInfection
-
IndicationHBV Infection
Chemical Information
-
CAS Number1578153-27-1
-
Formula Weight494.922
-
Molecular FormulaC21H20ClFN4O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C([C@H]1N(CC2=C(C(OC)=O)[C@H](C3=CC=C(F)C=C3Cl)N=C(C4=NC=CS4)N2)CCOC1)O
-
Chemical Name(S)-4-(((R)-6-(2-chloro-4-fluorophenyl)-5-(methoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholine-3-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kratochwil NA, et al. J Pharmacol Exp Ther. 2018 Feb 16. pii: jpet.117.245712.
molnova catalog
related products
-
Canocapavir
Canocapavir (ZM-H1505R) is a novel orally available HBV coat protein modulator with antiviral activity that induces conformational changes in the linker region of the HBV core protein, and can be used for the treatment of hepatitis B virus.
-
Lagociclovir
Lagociclovir (MIV-210), a nucleoside analogue, is an antiviral compound available for the treatment of HBV82 that inhibits the replication of wild-type hepatitis B virus (HBV) in human hepatocellular carcinoma cell lines that permanently express HBV.
-
RG7834
RG7834 is a highly selective and orally bioavailable inhibitor of HBV(HBsAg and HBeAg and HBV DNA with IC50s of 2.8, 2.6, and 3.2 nM, respectively, in dHepaRG Cells).
